Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.35 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.35 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.35 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.35 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
| ▸ | BAD | Q92934 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2466014 | 0.97 | ACHE (0.39) | ACHEORAI1ORAI2ORAI3TRPV6 | |
| Hydrochloric Acid SCHEMBL2463096 | 0.77 | ALDH1A1 (0.55) | RAB9A | |
| Hydrochloric Acid SCHEMBL2465644 | 0.76 | KMT2A (0.64) | ACHENPC1RAB9A | |
| Hydrochloric Acid SCHEMBL192911 | 0.75 | MMP2 (0.32) | PTPN1 | |
| SCHEMBL12267700 | 0.74 | ACHE (0.43) | ACHEORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL16433677 | 0.74 | SLC6A4 (0.56) | — | |
| SCHEMBL12240437 | 0.74 | SLC22A2 (0.44) | ACHEBCL2L1CA1CA2NPC1 | |
| SCHEMBL1108043 | 0.74 | SLC22A2 (0.50) | ACHEBCL2L1CA1CA2 | |
| SCHEMBL19892477 | 0.73 | KIF11 (0.48) | ACHEORAI1ORAI2ORAI3TRPV6 | |
| SCHEMBL14950479 | 0.73 | ACHE (0.45) | ACHEPTPN1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118707779-A | Electrochromic device, method of making and operating the same | 维特罗平板玻璃有限责任公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-114902128-B | Electrochromic device, method of making and operating the same | 维特罗平板玻璃有限责任公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-114902128-A | Electrochromic device, method of manufacturing and operating the same | 维特罗平板玻璃有限责任公司 | 2022-08-12 | — | — | CN | disclosed |
| US-8747984-B2 | Optical recording medium | TAIYO YUDEN CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8747984-B2 | Optical recording medium | TAIYO YUDEN CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-20130189545-A1 | OPTICAL RECORDING MEDIUM | TAIYO YUDEN CO., LTD. (JP) | 2013-07-25 | — | — | US | disclosed |
| US-20130189545-A1 | OPTICAL RECORDING MEDIUM | TAIYO YUDEN CO., LTD. (JP) | 2013-07-25 | — | — | US | disclosed |
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | KH NEOCHEM CO., LTD. (JP) | 2013-05-16 | — | — | US | disclosed |
| WO-2012008468-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | 協和発酵ケミカル株式会社 (JP) | 2012-01-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123494-A1 | COMPLEX COMPOUND AND OPTICAL RECORDING MEDIUM CONTAINING SAME | TRPA1, KCNH3, HCN3 | ACHE 518/4885ORAI1 104/4885ORAI2 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.